NovoCure Limited
NASDAQ:NVCR
18.57 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -207.043 | -92.534 | -58.351 | 19.808 | -7.23 | -63.559 | -61.662 | -131.845 | -111.581 | -80.682 | -77.37 |
| Depreciation & Amortization
| 10.969 | 10.624 | 10.251 | 9.15 | 8.46 | 9.006 | 7.677 | 5.652 | 3.153 | 1.962 | 1.216 |
| Deferred Income Tax
| 0.654 | 0 | 3.88 | -0.27 | -0.519 | 0.407 | 0.241 | 5.748 | 0.046 | 0.023 | 0.019 |
| Stock Based Compensation
| 115.608 | 106.955 | 94.9 | 75.721 | 52.416 | 39.846 | 27.116 | 22.139 | 11.86 | 4.624 | 5.12 |
| Change In Working Capital
| 29.655 | 11.796 | 29.069 | -8.521 | -24.332 | 11.413 | -6.758 | -9.441 | -4.363 | -0.152 | 6.796 |
| Accounts Receivables
| 29.414 | 2.547 | 5.27 | -30.354 | -36.496 | -4.151 | -23.228 | -6.339 | -1.309 | 1.174 | -0.398 |
| Inventory
| -8.919 | -4.342 | 2.483 | -2.935 | -1.159 | -0.529 | 3.524 | -11.955 | -10.148 | -1.554 | 1.479 |
| Accounts Payables
| 14.869 | 14.257 | 27.777 | 25.47 | 16.883 | 9.503 | -1.15 | 1.601 | 6.961 | -0.492 | 5.695 |
| Other Working Capital
| -5.709 | -0.666 | -6.461 | -0.702 | -3.56 | 6.59 | 14.096 | 7.252 | 0.133 | 0.72 | 0.02 |
| Other Non Cash Items
| -23.179 | -6.053 | 3.007 | 3.26 | -2.175 | 1.022 | 0.252 | 0.155 | 1.001 | -0.019 | 11.502 |
| Operating Cash Flow
| -73.336 | 30.788 | 82.756 | 99.148 | 26.62 | -1.865 | -33.134 | -107.592 | -99.884 | -74.244 | -52.717 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -27.093 | -21.358 | -24.17 | -14.968 | -10.485 | -6.711 | -7.366 | -17.664 | -10.271 | -2.319 | -3.627 |
| Acquisitions Net
| -211.241 | 118.599 | 120.664 | 457.879 | 41.182 | 3.795 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1,003.741 | -1,297.888 | -1,078.664 | -607.879 | -461.843 | -253.782 | -104.006 | -239.341 | -208.998 | -137.98 | 0 |
| Sales Maturities Of Investments
| 1,214.982 | 1,179.289 | 958 | 150 | 420.661 | 255 | 120 | 270 | 104 | 93 | 15.048 |
| Other Investing Activites
| 211.241 | -118.599 | -120.664 | -457.879 | -41.182 | -3.795 | -1.858 | -0.18 | -0.026 | 1.117 | -1.019 |
| Investing Cash Flow
| 184.148 | -139.957 | -144.834 | -472.847 | -51.667 | -5.493 | 6.77 | 12.815 | -115.295 | -46.182 | 10.402 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.01 | -0.028 | -0.026 | -150.028 | -0.031 | -100.084 | -0.076 | -0.07 | -0.063 | -0.063 | -58.047 |
| Common Stock Issued
| 4.416 | 5.224 | 4.546 | 3.37 | 2.467 | 1.835 | 1.54 | 0.616 | 252.133 | 0 | 191.738 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.005 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 11.381 | 10.295 | 21.182 | 586.867 | 59.245 | 167.618 | 3.704 | 74.578 | 24.924 | 2.208 | 49.627 |
| Financing Cash Flow
| 15.787 | 15.491 | 25.702 | 440.209 | 61.681 | 69.369 | 5.168 | 75.124 | 276.989 | 2.145 | 183.318 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.131 | -0.097 | -0.188 | 0.247 | 0.026 | 0.027 | 0.008 | 0.01 | 0 | 0 | 0 |
| Net Change In Cash
| 126.73 | -93.775 | -36.564 | 66.757 | 36.66 | 62.038 | -21.188 | -19.643 | 61.81 | -118.281 | 141.003 |
| Cash At End Of Period
| 242.564 | 115.834 | 209.609 | 246.173 | 179.416 | 142.756 | 78.592 | 99.78 | 119.423 | 57.613 | 175.894 |